Redox-active microneedles for disease management

Reactive oxygen and nitrogen species are essential to several biological functions, from maintaining cellular homeostasis to driving disease progression and aging. As such, the precise modulation of cellular redox states has emerged as a promising medical strategy. In parallel, microneedle technology has rapidly advanced over the past two decades, offering minimally invasive, targeted, and painless delivery of therapeutics. This review presents a comprehensive analysis of the emerging field of redox-active microneedles (RAMs), a novel class of wearable medical devices with broad potential for treating infected wounds, cancer, psoriasis, diabetes, arthritis, hair loss, skin aging, and potentially many other conditions. By integrating redox biology with advanced microneedle-based drug delivery systems, RAMs are poised to transform personalized and precision medicine, an evolution supported by a growing number of patents, clinical trials, and rapid advancements in catalytic, photodynamic, and nanomedicine research.

Authors

Institutions

Publication Details

Journal
Journal of Controlled Release
Published
2026-02-13
DOI
https://doi.org/10.1016/j.jconrel.2026.114717
Primary Topic
Advancements in Transdermal Drug Delivery
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Redox-active microneedles for disease management

Naizhen Yu, Ken D. Oakes, Ryan F. Donnelly, Dongchang Yang et al.
Journal of Controlled Release
Advancements in Transdermal Drug Delivery
article

Redox-active microneedles for disease management

Naizhen Yu, Ken D. Oakes, Ryan F. Donnelly, Dongchang Yang, Brian Youden, Andrew Carrier, Yongli Chen, Claudia Hodson, Kehinde Oni, Runqing Jiang, Mark Servos, Fathimath Chiarathodi, Xu Zhang
article en

Abstract

Reactive oxygen and nitrogen species are essential to several biological functions, from maintaining cellular homeostasis to driving disease progression and aging. As such, the precise modulation of cellular redox states has emerged as a promising medical strategy. In parallel, microneedle technology has rapidly advanced over the past two decades, offering minimally invasive, targeted, and painless delivery of therapeutics. This review presents a comprehensive analysis of the emerging field of redox-active microneedles (RAMs), a novel class of wearable medical devices with broad potential for treating infected wounds, cancer, psoriasis, diabetes, arthritis, hair loss, skin aging, and potentially many other conditions. By integrating redox biology with advanced microneedle-based drug delivery systems, RAMs are poised to transform personalized and precision medicine, an evolution supported by a growing number of patents, clinical trials, and rapid advancements in catalytic, photodynamic, and nanomedicine research.

Journal of Controlled ReleaseVol. 392
Cape Breton University (CA), Queen's University Belfast (GB), University of Waterloo (CA), Shenzhen Institute of Information Technology (CN), Regional Municipality of Waterloo (CA)
Good health and well-being
Openalex Percentile: Top 57%
Advancements in Transdermal Drug Delivery
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Redox-active microneedles for disease management — Naizhen Yu, Ken D. Oakes, et al. · Journal of Controlled Release (2026) | TGRS Research Map | TGRS